Abstract
The effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) administered separately or with anthelmintic albendazole (ABZ) on cellular immunity of mice with alveolar echinococcosis was studied. The proliferative activity of splenic T and B lymphocytes was the most stimulated after combined L-MTP-PE + ABZ therapy [from weeks 8 to 14 post-infection (p.i.)] that also induced a long-term development of protective Th1 response (the highest serum concentration of IFN-γ from weeks 8 to 18 p.i.). On the contrary, Th2 response (cytokine IL-5) in infected mice treated with L-MTP-PE was inhibited since week 8 p.i., but a significant long-term decrease in IL-5 concentration was found after combined L-MTP-PE + ABZ therapy until the end of the experiment (until week 26 p.i.). L-MTP-PE stimulated the production of superoxide anion (O2 −) by peritoneal macrophages from weeks 8 to 12 p.i., but the highest O2 − production was accordingly recorded after therapy L-MTP-PE + ABZ from weeks 8 to 18 p.i. Stimulation of cellular immunity of mice with alveolar echinococcis with L-MTP-PE and an interaction with ABZ’s anti-parasitic effect resulted in the greatest and long-term reduction of growth of Echinococcus multilocularis cysts in the host from week 10 p.i. until the end of the experiment.
Similar content being viewed by others
References
Adam A, Lederer E (1988) Muramylpeptides as immunomodulators. Immunology 1:205–214
Adinolfi LE, Bonventre PF, Vanderpas M, Eppstein DA (1985) Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral Leishmaniasis. Infect Immun 48:409–416
Altintas N, Orenay S, Reyhan E, Turk M, Asci M, Turel S, Yolasigmaz A, Altintas N (2007) Genotoxic effects of albendazole in patients medicated for cystic echinococcosis. Helminthologia 44:57–61
Antolová D, Miterpáková M, Reiterová K, Dubinský P (2006) Influence of anthelmintic baits on the occurrence of causative agents of helminthozoonoses in red foxes (Vulpes vulpes). Helminthologia 43:226–231
Asano T, McWatters A, An T, Matsushima K, Kleinerman ES (1994) Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. J Pharmacol Exp Ther 268:1032–1039
Capece BPS, Navarro M, Arcalis T, Castells G, Toribio L, Perez F, Carretero A, Ruberte J, Arboix M, Cristofol C (2003) Albendazole sulphoxide enantiomers in pregnant rats embryo concentrations and developmental toxicity. Vet J 165:266–275
Dieter P, Ambs P, Fityke E, Schwende H (1997) Lipopolysaccharide and liposome-encapsulated MTP-PE-induced cytotoxicity and release of eicosanoids, tumor necrosis factor-alpha and nitric oxide in liver macrophages. Adv Exp Med Biol 407:485–490
Dieter P, Hempel U, Malessa B, Fitzke E, Tran-Thi TA, MacLouf J, Creminon C, Kanaoka Y, Urade Y (1999) Lipopolysaccharide- and liposome-encapsulated MTP-PE-induced formation of eicosanoids, nitric oxide and tumor necrosis factor-alpha in macrophages. Adv Exp Med Biol 469:443–448
Dvorožňáková E, Borošková Z, Dubinský P, Tomašovičová O, Hříbalová V, Machnicka B (1999) Immunomodulative effect of muramyldipeptide in mice with larval toxocarosis. Parasitol Res 85:1034–1040
El-On J (2003) Benzimidazole treatment of cystic echinococcosis. Acta Trop 85:243–252
Emery I, Liance M, Deriaud E, Vuitton DA, Houin R, Leclerc C (1996) Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol 18:463–472
Fiorentino D, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O’Garra A (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444–3451
Gay B, Cardot JM, Schnell C, van Hoogevest P, Gygax D (1993) Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE. J Pharm Sci–US 82:997–1001
Gottstein B, Wunderlin E, Tanner I (1994) Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57B1/6J) or ‘resistant’ (C57B1/10) to secondary alveolar echinococcosis. Clin Exp Immunol 96:245–252
Gottstein B, Haag K, Walker M, Matsumoto J, Mejri A, Hemphill A (2006) Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol Int 55:S45–S49
Graichen DAS, Gottstein B, Matsumoto J, Müller N, Zanotto PMA, Ayala FJ, Haag KL (2007) Expression and diversity of Echinococcus multilocularis AgB genes in secondarily infected mice: evaluating the influence of T-cell immune selection on antigenic variation. Gene 392:98–105
Harraga S, Godot V, Bresson-Hadni S, Mantion G, Vuitton DA (2003) Profile of cytokine production within the periparasitic granuloma in human alveolar echinococcosis. Acta Trop 85:231–236
Hrčková G, Velebný S (1997) Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology 114:475–482
Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547–549
Hübner MP, Manfras BJ, Margos MC, Eiffler D, Hoffmann WH, Schulz-Key H, Kern P, Soboslay PT (2006) Echinococcus multilocularis metacestodes modulate cellular cytokine and chemokine release by peripheral blood mononuclear cells in alveolar echinococcosis patients. Clin Exp Immunol 145:243–251
Hui GS, Tam LQ, Chang SP, Case SE, Hashiro C, Siddiqui WA, Shiba T, Kusumoto S, Kotani S (1991) Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195. Infect Immun 59:1585–1591
Jenne L, Kilwinski J, Scheffold W, Kern P (1997) IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients. Clin Exp Immunol 109:90–97
Karpoff HM, Jarnagin W, Delman K, Fong Y (2000) Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance. Surgery 128:213–218
Kern P (2006) Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). Parasitol Int 55:S273–S282
Kinčeková J, Hrčková G, Auer H, Szilágyiová M, Hudáčková J, Stanislayová M, Poláček H, Šimeková K (2006) Clinical and serological study of human alveolar echinococcosis in Slovakia in relation to the outcome of chemotherapy. Helminthologia 43:213–219
Kizaki T, Kobayashi S, Ogasawara K, Day NK, Good RA, Onoe K (1991) Immune suppression induced by protoscoleces of Echinococcus multilocularis in mice. Evidence for the presence of CD8dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J Immunol 147:1659–1666
Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA (1998) Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite 5:231–237
Manfras BJ, Reuter S, Wendland T, Kern P (2002) Increased activation and oligoclonality of peripheral CD8+ T cells in the chronic human helminth infection alveolar echinococcosis. Infect Immun 70:1168–1174
Manfras BJ, Reuter S, Wendland T, Boehm BO, Kern P (2004) Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol 16:43–50
Melissen PM, van Vianen W, Leenen PJ, Bakker-Woundenberg IA (1993a) Tissue distribution and cellular distribution of liposomes encapsulating muramyltripeptide phosphatidyl ethanolamide. Tissue and cellular distribution of LE-MTPPE. Biotherapy 7:71–78
Melissen PM, van Vianen W, Bidjai O, van Marion M, Bakker-Woundenberg IA (1993b) Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-g (IFN-g) in experimental infection with Listeria monocytogenes. Biotherapy 6:113–124
Miterpáková M, Antolová D, Šefčíková Z, Stanko M, Dinkel A, Gašpar Š, Dubinský P (2006a) Echinococcus multilocularis in musk rat (Ondatra zibethicus): the first finding of the parasite in naturally infected rodent in the Slovak Republic. Helminthologia 43:76–80
Miterpáková M, Dubinský P, Reiterová K, Stanko M (2006b) Climate and environmental factors influencing Echinococcus multilocularis occurrence in the Slovak Republic. Ann Agric Environ Med 13:235–242
Pabst MJ, Beranova-Giorgianni S, Krueger JM (1999) Effects of muramyl peptides on macrophages, monokines, and sleep. Neuroimmunomodulation 6:261–283
Pagé M, Bajaouni N, Ciqo-Mars B, Lemieux P (1988) Optimization the tetrazolium based colorimetric assay for the measurement of cell number and cytotoxicity. Int J Immunopharmacol 10:785–793
Porubcová J, Dvorožňáková E, Ševčíková Z (2007a) Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis. Parasitol Res 101:751–760
Porubcová J, Dvorožňáková E, Ševčíková Z (2007b) Immune response of mice to Echinococcus multilocularis infection after therapy with amphotericin B colloidal dispersion. Helminthologia 44:47–56
Reimann J, Kaufmann SHE (1997) Alternative antigen processing pathways in anti-effective immunity. Curr Opin Immunol 9:462–469
Reiterová K, Miterpáková M, Turčeková L, Antolová D, Dubinský P (2005) Field evaluation of an intravital diagnostic test of Echinococcus multilocularis infection in red foxes. Vet Parasitol 128:65–71
Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P (2000) Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 46:451–456
Sehra S, Chugh L, Gangal SV (1998) Role of liposomes in selective proliferation of splenic lymphocytes. Mol Cell Biochem 183:133–139
Sher A, Fiorentino D, Caspar P, Pearce E, Mosmann T (1991) Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J Immunol 147:2713–2716
Šnábel V, Miterpáková M, D’Amelio S, Busi M, Bartková D, Turčeková L, Maddox-Hyttel C, Skuce P, Dubinský P (2006) Genetic structuring and differentiation of Echinococcus multilocularis in Slovakia assessed by sequencing and isoenzyme studies. Helminthologia 43:196–202
Šoltýs J, Quinn MT (1999) Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan. Infect Immun 67:244–252
Šoltýs J, Turčeková L, de Rycke PH (1999) The effect Echinococcus hydatid cyst fluid and protoscoleces on mouse peritoneal macrophages and spleen lymphocytes. Helminthologia 36:25–30
Souvannavong V, Brown S, Adam A (1988) The synthetic immunomodulator muramyl dipeptide (MDP) can stimulate activated B cells. Mol Immunol 25:385–391
Sturm D, Menzel J, Gottstein B, Kern P (1995) Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 63:1688–1697
Tanguay S, Bucana CD, Wilson MR, Fidler IJ, von Eschenbach AC, Killion JJ (1994) In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A. Cancer Res 5:5882–5888
ten Hagen TL, van Vianen W, Savelkoul HF, Heremans H, Buurman WA, Bakker-Woundenberg IA (1998) Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon. Infect Immun 66:1962–1967
Vuitton DA (2003) The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 85:119–132
Vuitton DA (2004) Echinococcosis and allergy. Clin Rev Allergy Immunol 26:93–104
Vuitton DA, Zhang SL, Yang Y, Godot V, Beurton I, Mantion G, Bresson-Hadni S (2006) Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int 55:S51–S55
Xu Z, Fidler IJ (1984) The in situ activation of cytotoxic properties in murine Kupffer cells by the systemic administration of whole Mycobacterium bovis organisms or muramyl tripeptide. Cancer Immunol Immunother 18:118–122
Zhang W, McManus DP (2006) Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol 47:24–41
Acknowledgments
This work was supported by the Slovak Research and Development Agency under the contract No. APVV-51-027605, the Slovak-Italian Science and Technology Cooperation for 2004–2007 (project “08 TAL”) and by the Slovak VEGA agency, grant No. 2/7186/27. The experimental protocols complied with the current Slovak ethic law.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dvorožňáková, E., Porubcová, J., Šnábel, V. et al. Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole. Parasitol Res 103, 919–929 (2008). https://doi.org/10.1007/s00436-008-1077-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-008-1077-2